Mv. Berridge et al., CYCLIC ADENOSINE-MONOPHOSPHATE PROMOTES CELL-SURVIVAL AND RETARDS APOPTOSIS IN A FACTOR-DEPENDENT BONE-MARROW-DERIVED CELL-LINE, Experimental hematology, 21(2), 1993, pp. 269-276
Hemopoietic growth factors promote cell survival, proliferation and di
fferentiation, but whether these processes, which often occur in conce
rt, are mediated through the same or different receptor signaling mech
anisms is not known. Using the bone marrow-derived IL-3-dependent cell
line, 32D, we show that dibutyryl cyclic adenosine monophosphate (dbc
AMP) retards the rapid loss of viable cells seen in the absence of IL-
3. This effect is shown to be concentration-dependent and detectable w
ithin 16 hours of culture and is not associated with cell differentiat
ion. At earlier times (2 to 7 hours), when no significant changes in c
ell numbers were observed, dbcAMP stimulated the reduction of dimethyl
thiazoldiphenyl tetrazolium bromide (MTT), and this effect was indisti
nguishable from that seen with IL-3. In contrast, control cells depriv
ed of growth factor showed a decline in MTT response over this period.
The effect of dbcAMP in maintaining cell viability and MTT responsive
ness was associated with a concentration-dependent inhibition of H-3-t
hymidine incorporation into DNA, and retardation of the intranucleosom
al cleavage of DNA that is associated with apoptosis. These results su
ggest that in 32D cells, cAMP can act to promote cell survival and ret
ard apoptosis, quite independently of cell proliferation, by stimulati
ng the activity of mitochondrial enzymes involved in MTT reduction.